Metagenomi Statistics
Total Valuation
Metagenomi has a market cap or net worth of $56.07 million. The enterprise value is -$146.46 million.
Important Dates
The last earnings date was Tuesday, May 13, 2025, after market close.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Metagenomi has 37.38 million shares outstanding. The number of shares has increased by 372.04% in one year.
| Current Share Class | 37.38M |
| Shares Outstanding | 37.38M |
| Shares Change (YoY) | +372.04% |
| Shares Change (QoQ) | -0.77% |
| Owned by Insiders (%) | 11.03% |
| Owned by Institutions (%) | 27.58% |
| Float | 23.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.23 |
| Forward PS | 2.64 |
| PB Ratio | 0.24 |
| P/TBV Ratio | 0.24 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.19 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -18.14% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | $224,074 |
| Profits Per Employee | -$385,886 |
| Employee Count | 202 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -5.42M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -77.10% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -77.10% |
| 50-Day Moving Average | 1.63 |
| 200-Day Moving Average | 2.40 |
| Relative Strength Index (RSI) | 45.35 |
| Average Volume (20 Days) | 356,395 |
Short Selling Information
The latest short interest is 2.96 million, so 7.93% of the outstanding shares have been sold short.
| Short Interest | 2.96M |
| Short Previous Month | 2.76M |
| Short % of Shares Out | 7.93% |
| Short % of Float | 12.71% |
| Short Ratio (days to cover) | 8.20 |
Income Statement
In the last 12 months, Metagenomi had revenue of $45.26 million and -$77.95 million in losses. Loss per share was -$2.11.
| Revenue | 45.26M |
| Gross Profit | -57.62M |
| Operating Income | -87.69M |
| Pretax Income | n/a |
| Net Income | -77.95M |
| EBITDA | -82.20M |
| EBIT | -87.69M |
| Loss Per Share | -$2.11 |
Full Income StatementBalance Sheet
The company has $248.31 million in cash and $45.78 million in debt, giving a net cash position of $202.53 million or $5.42 per share.
| Cash & Cash Equivalents | 248.31M |
| Total Debt | 45.78M |
| Net Cash | 202.53M |
| Net Cash Per Share | $5.42 |
| Equity (Book Value) | 234.86M |
| Book Value Per Share | 6.28 |
| Working Capital | n/a |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is -127.30%, with operating and profit margins of -193.73% and -172.21%.
| Gross Margin | -127.30% |
| Operating Margin | -193.73% |
| Pretax Margin | -184.18% |
| Profit Margin | -172.21% |
| EBITDA Margin | -181.61% |
| EBIT Margin | -193.73% |
| FCF Margin | n/a |